Because studies have shown that synthetic LXR agonist, such as GW3965 and T090317, can significantly attenuate the formation of atherosclerosis lesions via promotion of reverse cholesterol transpot (RCT), we suppose that compound K might play anti-atherosclerosis roles via LXRα activation. Here, NR1H3 is linked to atherosclerosis.